Cargando…
The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species
Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555932/ https://www.ncbi.nlm.nih.gov/pubmed/32854347 http://dx.doi.org/10.3390/antiox9090786 |
_version_ | 1783594122252124160 |
---|---|
author | Di Luigi, Luigi Duranti, Guglielmo Antonioni, Ambra Sgrò, Paolo Ceci, Roberta Crescioli, Clara Sabatini, Stefania Lenzi, Andrea Caporossi, Daniela Del Galdo, Francesco Dimauro, Ivan Antinozzi, Cristina |
author_facet | Di Luigi, Luigi Duranti, Guglielmo Antonioni, Ambra Sgrò, Paolo Ceci, Roberta Crescioli, Clara Sabatini, Stefania Lenzi, Andrea Caporossi, Daniela Del Galdo, Francesco Dimauro, Ivan Antinozzi, Cristina |
author_sort | Di Luigi, Luigi |
collection | PubMed |
description | Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major contributors to the disease. Indeed, different studies demonstrated how oxidative stress could contribute to the fibrotic process activation at the level of the skin and visceral organs. Emerging evidences highlight the beneficial effects of sildenafil, a phosphodiesterase type 5 inhibitor (PDE5i), which protects different cell lines from the cell damage induced by reactive oxygen species (ROS). These data make sildenafil a good candidate for therapeutic treatment aimed to protect biological macromolecules against oxidative damage, thus preserving cell viability. The purpose of this study was to evaluate the sensitivity of SSc dermal fibroblasts to an oxidative insult and the ability for sildenafil to prevent/reduce the DNA damage due to ROS action. Additionally, we evaluated the capacity for sildenafil to influence redox homeostasis and cytotoxicity, as well as cell proliferation and cell cycle progression. We demonstrated that SSc fibroblasts have an increased sensitivity to a pro-oxidant environment in comparison to healthy controls. The sildenafil treatment reduced ROS-induced DNA damage, counteracted the negative effects of ROS on cell viability and proliferation, and promoted the activity of specific enzymes involved in redox homeostasis maintenance. To our knowledge, in this report, we demonstrate, for the first time, that sildenafil administration prevents ROS-induced instability in human dermal fibroblasts isolated by SSc patients. These results expand the use of PDE5i as therapeutic agents in SSc by indicating a protective role in tissue damage induced by oxidative insult. |
format | Online Article Text |
id | pubmed-7555932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75559322020-10-19 The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species Di Luigi, Luigi Duranti, Guglielmo Antonioni, Ambra Sgrò, Paolo Ceci, Roberta Crescioli, Clara Sabatini, Stefania Lenzi, Andrea Caporossi, Daniela Del Galdo, Francesco Dimauro, Ivan Antinozzi, Cristina Antioxidants (Basel) Article Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by the increased deposition of extracellular matrix proteins such as collagen and fibronectin. Although the pathogenesis is not completely understood, a number of studies suggest that free radicals could be the major contributors to the disease. Indeed, different studies demonstrated how oxidative stress could contribute to the fibrotic process activation at the level of the skin and visceral organs. Emerging evidences highlight the beneficial effects of sildenafil, a phosphodiesterase type 5 inhibitor (PDE5i), which protects different cell lines from the cell damage induced by reactive oxygen species (ROS). These data make sildenafil a good candidate for therapeutic treatment aimed to protect biological macromolecules against oxidative damage, thus preserving cell viability. The purpose of this study was to evaluate the sensitivity of SSc dermal fibroblasts to an oxidative insult and the ability for sildenafil to prevent/reduce the DNA damage due to ROS action. Additionally, we evaluated the capacity for sildenafil to influence redox homeostasis and cytotoxicity, as well as cell proliferation and cell cycle progression. We demonstrated that SSc fibroblasts have an increased sensitivity to a pro-oxidant environment in comparison to healthy controls. The sildenafil treatment reduced ROS-induced DNA damage, counteracted the negative effects of ROS on cell viability and proliferation, and promoted the activity of specific enzymes involved in redox homeostasis maintenance. To our knowledge, in this report, we demonstrate, for the first time, that sildenafil administration prevents ROS-induced instability in human dermal fibroblasts isolated by SSc patients. These results expand the use of PDE5i as therapeutic agents in SSc by indicating a protective role in tissue damage induced by oxidative insult. MDPI 2020-08-25 /pmc/articles/PMC7555932/ /pubmed/32854347 http://dx.doi.org/10.3390/antiox9090786 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Di Luigi, Luigi Duranti, Guglielmo Antonioni, Ambra Sgrò, Paolo Ceci, Roberta Crescioli, Clara Sabatini, Stefania Lenzi, Andrea Caporossi, Daniela Del Galdo, Francesco Dimauro, Ivan Antinozzi, Cristina The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title | The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title_full | The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title_fullStr | The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title_full_unstemmed | The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title_short | The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species |
title_sort | phosphodiesterase type 5 inhibitor sildenafil improves dna stability and redox homeostasis in systemic sclerosis fibroblasts exposed to reactive oxygen species |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555932/ https://www.ncbi.nlm.nih.gov/pubmed/32854347 http://dx.doi.org/10.3390/antiox9090786 |
work_keys_str_mv | AT diluigiluigi thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT durantiguglielmo thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT antonioniambra thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT sgropaolo thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT ceciroberta thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT crescioliclara thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT sabatinistefania thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT lenziandrea thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT caporossidaniela thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT delgaldofrancesco thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT dimauroivan thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT antinozzicristina thephosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT diluigiluigi phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT durantiguglielmo phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT antonioniambra phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT sgropaolo phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT ceciroberta phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT crescioliclara phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT sabatinistefania phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT lenziandrea phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT caporossidaniela phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT delgaldofrancesco phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT dimauroivan phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies AT antinozzicristina phosphodiesterasetype5inhibitorsildenafilimprovesdnastabilityandredoxhomeostasisinsystemicsclerosisfibroblastsexposedtoreactiveoxygenspecies |